SUMMARY Enhanced biliary secretion and high faecal excretion of cholesterol are associated with increased cholesterol synthesis in coeliac disease. We have further investigated cholesterol synthesis in coeliac disease by determining the concentrations of faecal steroids and cholesterol precursors in serum, with and without a gluten free diet and while taking cholestyramine. The levels of unesterified methyl sterols and free and esterified lathosterol, but not those of squalene and desmosterol, were increased in proportion to the level of cholesterol synthesis, as measured with the sterol balance technique. Serum esterified methyl sterol concentrations were also slightly higher but, unlike free methyl sterols or lathosterol, they were not significantly correlated with cholesterol synthesis. The gluten free diet decreased the level of cholesterol synthesis, and the levels of lathosterol and free methyl sterols. There was less decrease in the concentration of esterified methyl sterols, and an insignificant decrease in the concentrations of squalene and desmosterol. Cholestyramine lowered the serum cholesterol concentration and increased that of serum free methyl sterols less in the patients than in the controls, and the increase was proportionate to increase of cholesterol elimination (or synthesis). The increase of serum free methyl sterols per unit of the increase of cholesterol elimination (or synthesis) was three times higher in the bile acid malabsorption caused by cholestyramine than in the cholesterol malabsorption caused by gluten enteropathy. On the other hand, the decrease in the level of serum cholesterol relative to the increase in cholesterol elimination (or synthesis) was higher in cholesterol malabsorption due to coeliac disease than in cholestyramine induced bile acid malabsorption. Effective secretion of newly synthesised and/or absorbed cholesterol directly into the bile could be a factor in the marked decrease of the serum cholesterol concentration in coeliac disease.
coeliac disease,4 5 its role in vivo is unclear. Also, there is no information on hepatic cholesterol synthesis in coeliac disease.
In the present study we explored cholesterol metabolism in coeliac disease further using two separate procedures to detect changes in cholesterol synthesis. These are the sterol balance technique and the quantification of cholesterol precursors in serum before and after gluten free diet, and before and after cholestyramine induced bile acid malabsorption. According to previous studies serum cholesterol precursors (Fig. 1) , especially free methyl sterols and lathosterol, are closely parallel with the changes of cholesterol synthesis, most likely in the liver.6A10 Thus the main aims of the present experiments were first to explore the significance of the cholesterol precursors for the detection of increased cholesterol synthesis in cholesterol malab- sorption of coeliac disease; and, second, to explore the differences in the effects of cholesterol and bile acid malabsorption on cholesterol metabolism.
Methods

PATIENTS
The present series comprised 12 patients with established coeliac disease. The correction of jejunal mucosal damage during a gluten free diet was regarded as an essential criterion for the diagnosis of coeliac disease. The control group consisted of six healthy subjects. All the subjects were informed of the purpose and design of the investigations, and they participated in the study as volunteers. The design of the study was approved by the ethical committee of the hospital. The faecal steroid data have, in part, been presented previously in Gastroenterology. 1 Every patient was hospitalised and put on a low cholesterol (125 mg/2400 kcal) solid food diet, which contained 100 g fat per day. The daily energy content of 30-35 kcal/kg of body weight was adjusted to maintain a constant body weight during the study. The controls were studied under similar conditions. All the subjects received 600 mg/day of both beta-sitosterol and chromic oxide (Cr2O3) (both from Orion Ltd., Helsinki, Finland) to correct, respectively, for a possible degradation of the sterol nucleus during intestinal transit,11 and for faecal flow.12 Both substances were given in capsules of 200 mg three times a day. When the diet and the markers had been used for seven days, a three day stool collection was made to study faecal steroid excretions and faecal fat content.
Five of the patients and the six control subjects also volunteered for the cholestyramine trial. For this the subjects received cholestyramine 32 g/day, in four doses daily for up to 14 days, a three day stool collection being made at the end of the treatment period.
CHEMICAL ANALYSIS Levels of serum squalene, free and esterified methyl sterols, and cholesterol were determined using thin-layer chromatography and gas liquid chromatography.6 Using mass spectrometric analysis,'3 it was found that fraction I contained A8-methostenol and some dihydrolanosterol, fraction II monounsaturated dimethyl sterol (4,4a-dimethyl A8), fraction III methostenol, fraction IV lanosterol and fraction V diunsaturated dimethyl sterol (4,4 dimethyl A8 24). The recovery of free methyl sterol added to serum was 93±2%. Gas liquid chromatography on a capillary column'4 was used for the quantification of cholesterol precursors when the effect of a gluten free diet on cholesterol synthesis was studied.
The faecal neutral steroids and bile acids were analysed using thin layer chromatography and gas liquid chromatography.'5 16 As the recovery of beta-sitosterol appeared to be practically complete in every case, the faecal steroid data are expressed in relation to chromic oxide. The stool fat determination was performed according to van 
Results
The clinical and faecal data for the 12 patients with coeliac disease, matched for age, sex and body weight with six controls, are presented in Table 1 .
The mean faecal bile acid excretion was normal, but the levels of faecal neutral steroids and faecal fat were clearly increased, indicating moderately severe coeliac disease. Cholesterol synthesis was twice as high in the patients as in the controls. With the gluten free diet all the data were clearly improved, even though cholesterol synthesis was still slightly increased.
SERUM METHYL STEROLS IN UNTREATED PATIENTS
Both the serum free and esterified methyl sterol levels were determined for six controls and for six patients with untreated coeliac disease ( Table 2 ). In Table 3 Effect ofthe gluten free diet (GFD) upon serum squalene, free and esterified methyl sterols, desmosterol, lathosterol and cholesterol levels in 12 patients. Mean±SEM Change -2-5+7-0
+37-1±11*6* +0-8±0-9 *p<005, tp<001., tp<0001 Table 1 .
group.bmj.com on June 25, 2017 -Published by http://gut.bmj.com/ Downloaded from terms of ,ug/mg of cholesterol the serum total free methyl sterol level was significantly higher for the patients than for the controls, whereas the total esterified methyl sterol content was not significantly different.
The percentage of esterified cholesterol was similar for the controls (71±1%) and the patients (72±1%), whereas the esterification of serum total methyl sterols was diminished by 20% (33±3% in controls vs 26±2% in patients).
EFFECT OF GLUTEN FREE DIET
Because the serum methyl sterol contents were significantly high in the untreated coeliac patients, the effect of gluten free diet on serum cholesterol and its precursors was evaluated in 12 patients. In this series the serum squalene, lathosterol and desmosterol levels were also measured.
While the gluten free diet significantly raised the serum free and esterified cholesterol levels in the patients (Table 3) , the serum levels of cholesterol precursors were lowered. Of the various precursors only squalene was not significantly decreased, whereas the serum total free methyl sterol level was reduced by one third (p<001). A decrease of similar magnitude was found in all the serum methyl sterol subfractions I-V. The esterified methyl sterol levels were also significantly decreased by the gluten free diet, but the reduction was only 18%, and was statistically significant for fractions II (monounsaturated dimethyl sterol) and III (methostenol).
The serum total desmosterol level was only insignificantly reduced by the gluten free diet while that of lathosterol showed a marked decrease during the treatment (Table 3 ).
The gluten free diet had no effect on the degree of esterification of serum cholesterol, but tended to increase that of cholesterol precursors, especially of methyl sterols, and less so those of desmosterol and lathosterol (Table 3) .
CORRELATIONS
An examination of the relationships between various precursors revealed a positive correlation between the free and esterified forms of serum methyl sterols (r=0.54, p<0 05), particularly with methostenol (r=0-87; p<0.001), desmosterol (r=0.77; p<0.01) and lathosterol (r=0-90; p<O-00l). In contrast to the esterified forms, the serum free methyl sterol and lathosterol, but not desmosterol, levels were positively correlated with the level of cholesterol synthesis (Fig. 2) .
CHOLESTYRAMINE TREATMENT
In the controls cholestyramine reduced the serum free cholesterol and increased faecal elimination of cholesterol by a factor of 3*3 as bile acids (Table 4) and serum total free methyl sterols by a factor of 4*6. The diunsaturated dimethyl sterol level exhibited the highest absolute and relative increase, while the level of methostenol was not significantly increased.
In the coeliac patients the faecal bile acid level and total steroid excretions were also increased by cholestyramine, but not as markedly as in the controls (Table 4 ). The decrease in the serum free cholesterol level (-10%) was insignificant and less than in the controls (-30%). The increase in serum free methyl sterols was also lower in the patients than in the controls mainly as a result of an only two-fold rise in fraction V as compared with Table 3 (c) The initial data of the controls are presented in Table 1 .
nine-fold increase in the controls. Accordingly, the proportion of methyl sterols in fraction V was increased in the controls (p<0-01), while it tended to be decreased in the patients. In the whole series the cholestyramine-induced changes in the faecal total steroid excretion were positively correlated with the corresponding changes in serum total free methyl sterols (Fig. 3 ) and in the subfraction V (r=0-60; p<005). The gluten free diet and cholestyramine studies revealed that the rise in free methyl sterols in terms of rig/mg of increase in cholesterol synthesis or 500- elimination, was three times higher with bile acid malabsorption than with cholesterol malabsorption (Fig. 4) . Calculations from the data for the subjects in Tables 3 and 4 revealed that a 1 mmol/l decrease in serum cholesterol required an increase of 27±7
[tmol/day/kg of body weight in the faecal total steroid excretion by cholesterol malabsorption in coeliac patients, and markedly more -that is, 81±18 [imolIday/kg of body weight (p<0-02) in the controls by cholestyramine-induced bile acid malabsorption. Discussion The present results revealed that the markedly higher level of cholesterol synthesis in coeliac disease is associated with a proportionate increase in serum free and esterified lathosterol, and free methyl sterols. This is less true for esterified methyl sterols and not true at all for squalene and desmosterol. The reason for the difference in esterification is that sterols with 27 carbons are esterified by lecithin:cholesterol acyl transferase (LCAT),18 19 while methyl sterols are not.20 The latter ones, especially 4a-methyl sterols, are esterified by acylcoenzyme A:cholesterol acyltransferase."1 22 Thus, serum methyl sterol esters are derived from tissues and include predominantly methostenols. Accordingly an increase in free lathosterol results in its proportionate esterification by lecithin:cholesterol acyltransferase while an increase in free methyl sterols is not followed by their esterification in serum.
Despite a greatly enhanced intestinal synthesis of cholesterol,4 5 In cholesterol malabsorption caused by neomycin the ratio of the decrease in serum cholesterol to the increase in cholesterol elimination (or synthesis) is markedly higher than with bile acid malabsorption.3i Similar results were obtained in the present study, indicating that cholesterol malabsorption and bile acid malabsorption reduce serum cholesterol dissimilarly. In fact, kinetic studies of serum lipoproteins also suggest that the mechanism for lowering the level of low density lipoprotein is different in the two conditions.32 3 In brief these findings suggest that the lowering of the serum cholesterol level with cholesterol malabsorption in coeliac disease is mainly attributable to a high biliary output of newly synthesised and/or absorbed cholesterol as compared with that released within very low density lipoprotein into serum, whereas in bile acid malabsorption a proportionately larger amount of newly synthesised and/or absorbed cholesterol is released into serum through increased very low density lipoprotein production and less is secreted directly into the bile. 
